Uji Validitas dan Reabilitas Kuesioner Naranjo untuk Mengukur Adverse Drug Reactions (ADRs)Pasien Aterosklerosis

I Nengah Satria Wirananda; Fitri  Apriliany; Novitarini

doi:10.30812/biocity.v4i2.5842

Authors

I Nengah Satria Wirananda Universitas Bumigora
Fitri Apriliany Universitas Bumigora
Novitarini Universitas Bumigora

DOI:

https://doi.org/10.30812/biocity.v4i2.5842

Keywords:

Adverse Drug Reactions (ADR); Atherosclerosis; Naranjo algorithm; Reliability; Validity

Abstract

Patients with atherosclerosis receive concomitant cardiovascular medications, and the use of multiple medications can increase the risk of adverse drug reactions (ADRs). ADRs assessment is crucial to differentiate drug side effects from other conditions, like comorbidities, drug interactions, or environmental factors. ADRs are generally measured using the Naranjo algorithm questionnaire. The purpose of this study is to determine the validity and reliability of the Naranjo questionnaire for measuring ADRs in patients with atherosclerosis. This study used a non-experimental, descriptive-analytical design with a cross-sectional approach and prospective observation. The subjects in this study were 30 patients with atherosclerosis, and data were collected using the Naranjo algorithm questionnaire. The results showed that the Naranjo algorithm questionnaire was valid, as the content validity test yielded a Pearson Correlation coefficient of >0.361. This instrument was deemed reliable because its Cronbach’s alpha was>0.60. Therefore, the Indonesian version of the Naranjo algorithm questionnaire is valid and reliable, and can be used to measure adverse drug reactions in patients with atherosclerosis.

References

Adondis, J., Mongi, J., Tiwow, G. A. R., and Palandi, R. R. (2019). Studi potensi interaksi obat pada pasien gagal jantung di instalasi rawat inap rumah sakit advent manado. Biofarmasetikal Tropis, 2(2):124–135. https://doi.org/10.55724/jbiofartrop.v2i2.125.

Apriyandi, R. A., Puspitasari, I. M., and Putriana, N. A. (2020). Efek samping penggunaan warfarin dan kombinasi warfarin dengan obat lain. Farmaka, 18(2):132–145.

Astuti, N. N. W. P., Kurniawati, D., and Mustaqimah (2023). Studi kejadian efek samping pengobatan rheumatoid arthitis pasien rawat jalan di rumah sakit ulin. Jurnal Farmasi SYIFA, 1(2):91–97. https://doi.org/10.63004/jfs.v1i2.229.

Dasopang, E. S., Hasanah, F., and Nisak, C. (2019). Analisis deskriptif efek samping penggunaan obat antituberculosis pada pasien tbc di rsud dr pirngadi medan. Jurnal Penelitian Farmasi Herbal, 2(1):44–49.

Dewiyani, A. A. I. C. and Fadila, R. (2023). Uji validitas dan reliabilitas kuesioner pengetahuan masyarakat tentang program jkn. 11(1):307–315. https://doi.org/10.37824/jkqh.v11i1.2023.462.

Ernawati, H., Ikawati, Z., Puspitasari, I., Abdoellah, S. A., and Kurniawati, F. (2025). Evaluation of adverse drug reaction reporting on the badan pom website in yogyakarta special region. Jurnal Manajemen dan Pelayanan Farmasi, 15(3):208. https://doi.org/10.22146/jmpf.105134.

Hetherington, I. and Totary-Jain, H. (2022). Anti-atherosclerotic therapies: Milestones, challenges, and emerging innovations. Molecular Therapy, 30(10):3106–3117. https://doi.org/10.1016/j.ymthe.2022.08.024.

Longpre-Poirier, C., Dougoud, J., Moussaoui, F., Vilme, J., Desjardins, G., and Cartier, L. (2022). Sex and gender and allostatic mechanisms of cardiovascular risk and disease. Canadian Journal of Cardiology, 38(12):1–8. https://doi.org/10.1016/j.cjca.2022.09.011.

Maharani, A., Sujarwoto, Praveen, D., and Oceandy, D. (2019). Cardiovascular disease risk factor prevalence and estimated 10-year cardiovascular risk scores in indonesia: The smarthealth extend study. PLOS ONE, pages 1–13.

Meyta Sari, C. and Suprapti, B. (2024). Adverse drug reactions reporting profile in tertiary referral hospital: A retrospective pharmacovigilance study in indonesia. Jurnal Farmasi dan Ilmu Kefarmasian Indonesia, 11(2):174–183. https://doi.org/10.20473/jfiki.v11i22024.174-183.

Pratama, I. S., Aini, S. R., Hidayat, L. H., Mursyid, M. H., and Muharromi, S. U. (2021). No title. 16(2):198-202. https://doi.org/10.29303/jpm.v16i2.2364.

Purnomo, D. (2018). Uji validitas dan reliabilitas step test sebagai alat ukur keseimbangan pada lansia. Jurnal Fisioterapi dan Rehabilitasi, 2(2):65–71.

Puspasari, D., Wisaksana, R., and Ruslami, R. (2018). Gambaran efek samping dan kepatuhan terapi antiretroviral pada pasien hiv di rumah sakit dr hasan sadikin bandung tahun 2015. JSK, 3.

Ristian, D., Yuliandhari, R., Wulansari, S., and Prayogo, D. (2024). Algoritme naranjo sebagai metode identifikasi dini efek samping obat pada pasien tuberkulosis resisten obat di RS Muhammadiyah Lamongan. 5(2):142–149.

Sitepu, R., Sefiana, E., and Susanto, H. (2021). Evaluasi penggunaan obat antihipertensi ace inhibitor lisinopril terhadap kejadian batuk kering pada pasien hipertensi di komunitas gereja di Kabupaten Malang. Jurnal Wijata, 8(2):51–57.

Surya, A. P., Fauziah, and Nurhayati (2020). Sistem diagnosis penyakit hipokalemia menggunakan gabungan metode forward chaining dan certainty factor. Jurnal JTIK (Jurnal Teknologi Informasi dan Komunikasi), 5(2):213. https://doi.org/10.35870/jtik.v5i2.180.

Wong, M. Y. Z., Yap, J., Huang, W., Tan, S. Y., and Yeo, K. K. (2021). Impact of age and sex on subclinical coronary atherosclerosis in a healthy asian population. JACC, 1(1). https://doi.org/10.1016/j.jacasi.2021.05.002.

Yuwindry, I. (2021). Pengaruh efek samping obat off label terhadap kualitas hidup pasien lupus di RSUD Ulin Banjarmasin. Journal of Pharmacy Science and Practice, 8(2):54–61.

Zahra, F., Satryo, O., Wahyuni, D., Suprapti, B., Nilamsari, W. P., and Alsagaff, M. Y. (2025). Exploring side effects of warfarin in outpatients at tertiary hospital in indonesia. Jurnal Farmasi dan Ilmu Kefarmasian Indonesia, 12(2):142–150. https://doi.org/10.20473/jfiki.v12i22025.142-150.

Zheng, W., Huang, X., Wang, X., Suo, M., Yan, Y., Gong, W., Ai, H., Que, B., and Nie, S. (2024). Impact of

multimorbidity patterns on outcomes and treatment in patients with coronary artery disease. European Heart Journal Open, 4(2):1–8. https://doi.org/10.1093/ehjopen/oeae009.